Pharmacy should be at the centre of anti-obesity drive, says RPS
Pharmacy should be at the centre of the government's anti-obesity drive, the Royal Pharmaceutical Society (RSP) has said.
Following the launch of Public Health England's 'Better...
Boris Johnson uses own struggles with weight to urge UK to get fit
Prime Minister Boris Johnson urged Britain to lose “a little bit of weight” on Monday, using his own struggle with his weight before he...
Obesity increases risks of death from Covid-19
People who are obese or overweight are at increased risk of death or severe illness from Covid-19, a report by Public Health England (PHE)...
DHSC issues supply notification for Enalapril 20mg tablets
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Enalapril 20mg tablets.
Enalapril 20mg tablets will remain out of...
Steve Anderson to join executive board of Phoenix Europe
Phoenix UK boss Steve Anderson has been appointed to the executive board of the Phoenix in Europe with effect from September 1.
Anderson will continue as...
Everybody should get a flu vaccine, Johnson says announcing expanded flu programme
Prime Minister Boris Johnson said on Friday that everybody should get a flu vaccination to prevent the health service getting overwhelmed in winter if...
Pharmacy2U founder Daniel Lee invests £8m in first automated pharmacy dispensing hub
The founder and former chief executive of Pharmacy2U has announced plans to invest £8 million in a facility that will allow independently-owned community pharmacies...
Tory peer lashes out at government over plight of pharmacy during pandemic
Lord Michael Grade of Yarmouth has criticised the government’s response to the plight of community pharmacists as frontline workers during the current Covid-19 pandemic...
MHRA issues defect information notice for Ecalta 100mg powder
The Medicines and Health products Regulatory Agency (MHRA) has issued a class four medicines defect information notice for Ecalta 100mg powder for concentrate solution...
MHRA recalls Irinotecan Hydrochloride Concentrate for Solution for Infusion
The Medicines and Health products Regulatory Agency (MHRA) has issued a class three medicines recall notice for Irinotecan Hydrochloride Concentrate for Solution for Infusion...
Current Issue March 2024
